We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
The Propel system consists of modular hardware and software that when integrated together
creates a sophisticated segmented flow reactor solution for organic chemistry. By adopting segmented flow technology the Propel enables the pursuit of chemical reactions not easily pursued with typical traditional laboratory equipment. Propel has successfully performed reactions routinely run in a microwave, duplicating the extreme temperatures but allowing high pressures enabling the use of low boiling point and greener solvents such as methanol and ethanol.
With the Propel, exploration of reaction conditions for screening and optimization of small
volume reaction segments (<1 mL) enables more experiments while using less starting
material. The Propel’s optional online integration LC/MS for either Analysis or Prep Mode there’s no queuing up for analysis, every experiment is automatically diluted, injected, analyzed and with Propel’s automatic data reporting, each segment’s information is instantly made available for review.
Once optimized reactions can instantly scaled to 100s of grams using the same method as that used to make milligrams.
Seven years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
